Logo image of BIVI

BIOVIE INC (BIVI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BIVI - US09074F5044 - Common Stock

1.16 USD
+0.03 (+2.65%)
Last: 12/31/2025, 8:00:01 PM
1.16 USD
0 (0%)
After Hours: 12/31/2025, 8:00:01 PM
Fundamental Rating

3

BIVI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 530 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for BIVI as it has an excellent financial health rating, but there are worries on the profitability. BIVI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BIVI had negative earnings in the past year.
In the past year BIVI has reported a negative cash flow from operations.
BIVI had negative earnings in each of the past 5 years.
BIVI had a negative operating cash flow in each of the past 5 years.
BIVI Yearly Net Income VS EBIT VS OCF VS FCFBIVI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -69.22%, BIVI is doing worse than 62.26% of the companies in the same industry.
BIVI has a Return On Equity of -74.50%. This is comparable to the rest of the industry: BIVI outperforms 54.53% of its industry peers.
Industry RankSector Rank
ROA -69.22%
ROE -74.5%
ROIC N/A
ROA(3y)-119.07%
ROA(5y)-705.14%
ROE(3y)-211.57%
ROE(5y)-997.19%
ROIC(3y)N/A
ROIC(5y)N/A
BIVI Yearly ROA, ROE, ROICBIVI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BIVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BIVI Yearly Profit, Operating, Gross MarginsBIVI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, BIVI has more shares outstanding
The number of shares outstanding for BIVI has been increased compared to 5 years ago.
There is no outstanding debt for BIVI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BIVI Yearly Shares OutstandingBIVI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
BIVI Yearly Total Debt VS Total AssetsBIVI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

BIVI has an Altman-Z score of -17.15. This is a bad value and indicates that BIVI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BIVI (-17.15) is worse than 80.38% of its industry peers.
There is no outstanding debt for BIVI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.15
ROIC/WACCN/A
WACCN/A
BIVI Yearly LT Debt VS Equity VS FCFBIVI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M -40M

2.3 Liquidity

BIVI has a Current Ratio of 15.83. This indicates that BIVI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BIVI (15.83) is better than 92.26% of its industry peers.
A Quick Ratio of 15.83 indicates that BIVI has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 15.83, BIVI belongs to the best of the industry, outperforming 92.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.83
Quick Ratio 15.83
BIVI Yearly Current Assets VS Current LiabilitesBIVI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

BIVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.36%, which is quite impressive.
EPS 1Y (TTM)84.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 60.24% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.11%
EPS Next 2Y72.68%
EPS Next 3Y69.51%
EPS Next 5Y60.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BIVI Yearly Revenue VS EstimatesBIVI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2031 2032 50M 100M 150M 200M 250M
BIVI Yearly EPS VS EstimatesBIVI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BIVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 0.26, which indicates a rather cheap valuation of BIVI.
99.81% of the companies in the same industry are more expensive than BIVI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, BIVI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.26
BIVI Price Earnings VS Forward Price EarningsBIVI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIVI Per share dataBIVI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6 -8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BIVI's earnings are expected to grow with 69.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.68%
EPS Next 3Y69.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BIVI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

BIOVIE INC

NASDAQ:BIVI (12/31/2025, 8:00:01 PM)

After market: 1.16 0 (0%)

1.16

+0.03 (+2.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10 2025-11-10
Earnings (Next)02-09 2026-02-09
Inst Owners17.91%
Inst Owner Change7.78%
Ins Owners0.24%
Ins Owner Change0%
Market Cap8.75M
Revenue(TTM)N/A
Net Income(TTM)-18.57M
Analysts82.86
Price Target12.24 (955.17%)
Short Float %2.33%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-80%
PT rev (3m)-78.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-391.67%
EPS NY rev (3m)-391.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.26
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)-8.92
EYN/A
EPS(NY)4.42
Fwd EY380.74%
FCF(TTM)-2.45
FCFYN/A
OCF(TTM)-2.45
OCFYN/A
SpS0
BVpS3.31
TBVpS3.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -69.22%
ROE -74.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-119.07%
ROA(5y)-705.14%
ROE(3y)-211.57%
ROE(5y)-997.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.83
Quick Ratio 15.83
Altman-Z -17.15
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.94%
EPS Next Y33.11%
EPS Next 2Y72.68%
EPS Next 3Y69.51%
EPS Next 5Y60.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.26%
OCF growth 3YN/A
OCF growth 5YN/A

BIOVIE INC / BIVI FAQ

What is the fundamental rating for BIVI stock?

ChartMill assigns a fundamental rating of 3 / 10 to BIVI.


Can you provide the valuation status for BIOVIE INC?

ChartMill assigns a valuation rating of 4 / 10 to BIOVIE INC (BIVI). This can be considered as Fairly Valued.


How profitable is BIOVIE INC (BIVI) stock?

BIOVIE INC (BIVI) has a profitability rating of 0 / 10.


What is the expected EPS growth for BIOVIE INC (BIVI) stock?

The Earnings per Share (EPS) of BIOVIE INC (BIVI) is expected to grow by 33.11% in the next year.